292 related articles for article (PubMed ID: 11678896)
1. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
[TBL] [Abstract][Full Text] [Related]
3. Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4 perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype.
Walton JA; Lydyard PM; Nathwani A; Emery V; Akbar A; Glennie MJ; Porakishvili N
Br J Haematol; 2010 Jan; 148(2):274-84. PubMed ID: 19895614
[TBL] [Abstract][Full Text] [Related]
4. A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia.
Martín AP; Martín ER; García-Suárez J; Arriagada FC; del Puerto Hernandez-Fuentes M; Vilaplana JC; Alvarez-Mon Soto M
Eur J Haematol; 1997 Aug; 59(2):89-99. PubMed ID: 9293856
[TBL] [Abstract][Full Text] [Related]
5. Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells.
Pedroza-Seres M; Linares M; Voorduin S; Enrique RR; Lascurain R; Garfias Y; Jimenez-Martinez MC
Br J Ophthalmol; 2007 Oct; 91(10):1393-8. PubMed ID: 17475702
[TBL] [Abstract][Full Text] [Related]
6. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions.
Yawalkar N; Egli F; Hari Y; Nievergelt H; Braathen LR; Pichler WJ
Clin Exp Allergy; 2000 Jun; 30(6):847-55. PubMed ID: 10848903
[TBL] [Abstract][Full Text] [Related]
7. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
8. Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.
Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
Clin Diagn Lab Immunol; 1995 Mar; 2(2):249-52. PubMed ID: 7697540
[TBL] [Abstract][Full Text] [Related]
9. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
[TBL] [Abstract][Full Text] [Related]
11. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens.
Rutella S; Rumi C; Lucia MB; Etuk B; Cauda R; Leone G
Immunol Lett; 1998 Jan; 60(1):51-5. PubMed ID: 9541463
[TBL] [Abstract][Full Text] [Related]
13. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
[TBL] [Abstract][Full Text] [Related]
14. HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells.
Lewis DE; Yang L; Luo W; Wang X; Rodgers JR
AIDS; 1999 Jun; 13(9):1029-33. PubMed ID: 10397532
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
[TBL] [Abstract][Full Text] [Related]
16. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
Lancki DW; Hsieh CS; Fitch FW
J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
[TBL] [Abstract][Full Text] [Related]
18. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]